KYAN Therapeutics, in partnership with Powbab, a superfood company for better health, has developed an optimized health supplement to help address Non-Alcoholic Fatty Liver Disease (NAFLD) leveraging on KYAN’s proprietary artificial intelligence platform, Optim.AI. The patent-pending formula has been commercially launched by Powbab as “Liver Cleanse Detox.” The product is now available for worldwide delivery. You can purchase the product and read about the research at: https://www.powbab.com/products/liver-cleanse-detox.
- Co-Founders of KYAN Featured on The Straits Times
- AI Platform Aids Treatment for Relapsed Lymphoma